25 years of the WHO essential medicines lists: progress and challenges.
AffiliationBoston University School of Public Health, Boston, MA 02118, USA. email@example.com <firstname.lastname@example.org>
MetadataShow full item record
AbstractThe first WHO essential drugs list, published in 1977, was described as a peaceful revolution in international public health. The list helped to establish the principle that some medicines were more useful than others and that essential medicines were often inaccessible to many populations. Since then, the essential medicines list (EML) has increased in size; defining an essential medicine has moved from an experience to an evidence-based process, including criteria such as public-health relevance, efficacy, safety, and cost-effectiveness. High priced medicines such as antiretrovirals are now included. Differences exist between the WHO model EML and national EMLs since countries face varying challenges relating to costs, drug effectiveness, morbidity patterns, and rationality of prescribing. Ensuring equitable access to and rational use of essential medicines has been promoted through WHO's revised drug strategy. This approach has required an engagement by WHO on issues such as the effect of international trade agreements on access to essential medicines and research and development to ensure availability of new essential medicines.
- A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
- Authors: Baxi SM, Beall R, Yang J, Mackey TK
- Issue date: 2019 Sep 18
- Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
- Authors: Twagirumukiza M, Annemans L, Kips JG, Bienvenu E, Van Bortel LM
- Issue date: 2010 Mar
- [The essentiality and rationality of the Brazilian national listing of essential medicines].
- Authors: Yamauti SM, Bonfim JR, Barberato-Filho S, Lopes LC
- Issue date: 2017 Mar
- Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
- Authors: Rowlands A, Ameyaw E, Rutagarama F, Dipesalema J, Majaliwa ES, Mbogo J, Ogle GD, Chanoine JP
- Issue date: 2018
- Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
- Authors: Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D
- Issue date: 2013 Oct